Avet Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET LIFESCIENCES, and what generic and branded alternatives to AVET LIFESCIENCES drugs are available?
AVET LIFESCIENCES has thirty-seven approved drugs.
Drugs and US Patents for Avet Lifesciences
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avet Lifesciences | LEVOFLOXACIN | levofloxacin | INJECTABLE;INJECTION | 202590-002 | Jan 24, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Avet Lifesciences | NEOSTIGMINE METHYSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 208230-001 | Nov 25, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Avet Lifesciences | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 079025-002 | Sep 17, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.